Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
196 | 3 | LUNG CANCER//NON SMALL CELL LUNG CANCER//THORAC SURG | 53631 |
1149 | 2 | SMALL CELL LUNG CANCER//CYFRA 21 1//BOMBESIN | 9866 |
1330 | 1 | SMALL CELL LUNG CANCER//AMRUBICIN//PROPHYLACTIC CRANIAL IRRADIATION | 2726 |
3616 | 1 | BOMBESIN//GASTRIN RELEASING PEPTIDE//NEUROMEDIN B | 1978 |
8087 | 1 | SW MED SIMMONS CANC//K RAS GENOTYPES//LUNG CANCER | 1317 |
8757 | 1 | LARGE CELL NEUROENDOCRINE CARCINOMA//TYPICAL CARCINOID//ATYPICAL CARCINOID | 1251 |
10793 | 1 | CYFRA 21 1//PROGRP//CYTOKERATIN 19 FRAGMENT | 1062 |
17908 | 1 | NEUROEPITHELIAL BODIES//PULMONARY NEUROENDOCRINE CELLS//PULMONARY ENDOCRINE CELLS | 603 |
19113 | 1 | SQUAMOUS CELL CARCINOMA ANTIGEN//SERPINB3//SCC ANTIGEN | 543 |
22909 | 1 | SMALL CELL LUNG CANCER CELL LINES//2G3 ESOPHAGEAL MONOCLONAL ANTIBODY//ADJUVANT THERAPY MONOCLONAL ANTIBODIES | 386 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | SMALL CELL LUNG CANCER | authKW | 1304100 | 9% | 45% | 915 |
2 | CYFRA 21 1 | authKW | 453537 | 2% | 70% | 203 |
3 | BOMBESIN | authKW | 418653 | 3% | 42% | 315 |
4 | GASTRIN RELEASING PEPTIDE | authKW | 320664 | 2% | 53% | 191 |
5 | AMRUBICIN | authKW | 260716 | 1% | 83% | 99 |
6 | NEUROMEDIN B | authKW | 222128 | 1% | 84% | 83 |
7 | SQUAMOUS CELL CARCINOMA ANTIGEN | authKW | 190534 | 1% | 64% | 94 |
8 | PROPHYLACTIC CRANIAL IRRADIATION | authKW | 154814 | 1% | 58% | 83 |
9 | LARGE CELL NEUROENDOCRINE CARCINOMA | authKW | 147872 | 1% | 48% | 97 |
10 | NEUROEPITHELIAL BODIES | authKW | 118498 | 0% | 81% | 46 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 81486 | 47% | 1% | 4666 |
2 | Respiratory System | 26919 | 14% | 1% | 1389 |
3 | Pathology | 4992 | 7% | 0% | 677 |
4 | Endocrinology & Metabolism | 1080 | 5% | 0% | 520 |
5 | Medical Laboratory Technology | 823 | 2% | 0% | 174 |
6 | Pharmacology & Pharmacy | 640 | 7% | 0% | 729 |
7 | Anatomy & Morphology | 611 | 1% | 0% | 124 |
8 | Critical Care Medicine | 603 | 2% | 0% | 185 |
9 | Cell Biology | 501 | 6% | 0% | 572 |
10 | Medicine, Research & Experimental | 414 | 4% | 0% | 363 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PEPTIDE S | 33697 | 0% | 39% | 27 |
2 | DIGEST DIS BRANCH | 27141 | 1% | 17% | 51 |
3 | THORAC SURG | 24855 | 4% | 2% | 415 |
4 | CELLULAR MOL NEUROPHARMACOL GRP | 21751 | 0% | 45% | 15 |
5 | THORAC ONCOL | 20288 | 1% | 5% | 120 |
6 | ENDOCRINE POLYPEPTIDE CANC | 15534 | 0% | 15% | 33 |
7 | UNIV HOSP CPE HCPA | 11196 | 0% | 29% | 12 |
8 | CUNEO LUNG CANC STUDY GRP | 10443 | 0% | 55% | 6 |
9 | MED MED EXPTL MED SECT | 10215 | 0% | 80% | 4 |
10 | SW MED SIMMONS CANC | 10215 | 0% | 80% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | LUNG CANCER | 89328 | 4% | 8% | 358 |
2 | JOURNAL OF THORACIC ONCOLOGY | 21419 | 1% | 5% | 137 |
3 | PEPTIDES | 12783 | 2% | 2% | 190 |
4 | JOURNAL OF CLINICAL ONCOLOGY | 11087 | 2% | 1% | 243 |
5 | CLINICAL LUNG CANCER | 10877 | 1% | 6% | 54 |
6 | CANCER | 10491 | 3% | 1% | 309 |
7 | CANCER TREATMENT REPORTS | 7593 | 1% | 3% | 73 |
8 | SEMINARS IN ONCOLOGY | 7092 | 1% | 2% | 109 |
9 | BRITISH JOURNAL OF CANCER | 6979 | 2% | 1% | 204 |
10 | ANTICANCER RESEARCH | 6963 | 2% | 1% | 211 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |